Predict (USAID)
Predict (USAID)
Predict was a project funded by the United States Agency for International Development (USAID) with the aim of identifying new diseases that could become a threat to human health. The project was part of the Emerging Pandemic Threats program.
History[edit | edit source]
The Predict project was launched in 2009 as a response to the Global spread of H1N1 in 2009. It was a part of the USAID's Emerging Pandemic Threats program. The project was implemented by a consortium of organizations led by the University of California, Davis.
Objective[edit | edit source]
The main objective of the Predict project was to improve global biosecurity by enabling early detection and rapid response to emerging diseases that could pose a significant threat to human health. The project aimed to achieve this by strengthening global capacity for disease surveillance and diagnostics.
Activities[edit | edit source]
The Predict project carried out a range of activities to achieve its objectives. These included:
- Conducting surveillance for new diseases in wildlife populations, particularly in bats, rodents, and non-human primates.
- Developing and implementing new diagnostic tools for disease detection.
- Training local scientists and health workers in disease surveillance and diagnostics.
- Collaborating with local communities and governments to improve disease surveillance and response systems.
Impact[edit | edit source]
The Predict project made significant contributions to global health security. It identified over 1,000 new viruses, including a new strain of Ebola virus. The project also played a key role in the response to the 2014–2016 Ebola outbreak in West Africa, providing critical diagnostic support and training.
See also[edit | edit source]
References[edit | edit source]
Predict (USAID) Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD